Evidence map›Paper›PMID 36475849›Full record

ArticleMicrobiology spectrum2023

Genetic Adaptation and Acquisition of Macrolide Resistance in Haemophilus spp. during Persistent Respiratory Tract Colonization in Chronic Obstructive Pulmonary Disease (COPD) Patients Receiving Long-Term Azithromycin Treatment.

Anna Carrera-Salinas, Aida González-Díaz, Rachel L Ehrlich, Dàmaris Berbel, Fe Tubau, Xavier Pomares, Junkal Garmendia, M Ángeles Domínguez, Carmen Ardanuy, Daniel Huertas and 5 more

Open access · goldAbstract read
In one paragraph

Article in Microbiology spectrum, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 2 pooled it
3.1field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 2 syntheses or guidelines pooled it, 23 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Extensively drug-resistant Haemophilus influenzae isolated in Geneva, Switzerland.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2025
    Article
  11. Genomic profiling of cefotaxime-resistantFrontiers in microbiology · 2025
    Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Imipenem heteroresistance but not tolerance inFrontiers in microbiology · 2023
    Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 5 institutions in 2 countries.

Anna Carrera-SalinasMicrobiology Department, Hospital Universitari de Bellvitge, IDIBELL-UB, Barcelona, Spain.
Aida González-DíazMicrobiology Department, Hospital Universitari de Bellvitge, IDIBELL-UB, Barcelona, Spain.
Rachel L EhrlichDepartment of Microbiology and Immunology, Center for Genomic Sciences, Drexel University College of Medicine, Philadelphia, Pennsylvania, USA.
Dàmaris BerbelMicrobiology Department, Hospital Universitari de Bellvitge, IDIBELL-UB, Barcelona, Spain.
Fe TubauMicrobiology Department, Hospital Universitari de Bellvitge, IDIBELL-UB, Barcelona, Spain.
Xavier PomaresDepartment of Respiratory Medicine, Hospital de Sabadell, Hospital Universitari Parc Taulí, Institut d'Investigació i Innovació Parc Taulí I3PT, Universitat Autònoma de Barcelona, Sabadell, Spain.
Junkal GarmendiaResearch Network for Respiratory Diseases (CIBERES), ISCIII, Madrid, Spain.
M Ángeles DomínguezMicrobiology Department, Hospital Universitari de Bellvitge, IDIBELL-UB, Barcelona, Spain.
Carmen ArdanuyMicrobiology Department, Hospital Universitari de Bellvitge, IDIBELL-UB, Barcelona, Spain.
Daniel HuertasDepartment of Respiratory Medicine, Hospital Residència Sant Camil, Consorci Sanitari Alt Penedès-Garraf, Barcelona, Spain.
Alicia MarínResearch Network for Respiratory Diseases (CIBERES), ISCIII, Madrid, Spain.
Conchita MontónDepartment of Respiratory Medicine, Hospital de Sabadell, Hospital Universitari Parc Taulí, Institut d'Investigació i Innovació Parc Taulí I3PT, Universitat Autònoma de Barcelona, Sabadell, Spain.
Joshua Chang MellDepartment of Microbiology and Immunology, Center for Genomic Sciences, Drexel University College of Medicine, Philadelphia, Pennsylvania, USA.
Salud SantosResearch Network for Respiratory Diseases (CIBERES), ISCIII, Madrid, Spain.
Sara MartiMicrobiology Department, Hospital Universitari de Bellvitge, IDIBELL-UB, Barcelona, Spain.ORCID 0000-0002-0405-2305
Instituto de Salud Carlos III · ESDrexel University · USUniversitat Autònoma de Barcelona · ESBellvitge University Hospital · ESConsorci Sanitari Garraf · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Patients with chronic obstructive pulmonary disease (COPD) benefit from the immunomodulatory effect of azithromycin, but long-term administration may alter colonizing bacteria. Our goal was to identify changes in Haemophilus influenzae and Haemophilus parainfluenzae during azithromycin treatment. Fifteen patients were followed while receiving prolonged azithromycin treatment (Hospital Universitari de Bellvitge, Spain). Four patients (P02, P08, P11, and P13) were persistently colonized by H. influenzae for at least 3 months and two (P04 and P11) by

Indexed as

Haemophilus InfectionsPulmonary Disease, Chronic ObstructiveAnti-Bacterial AgentsAzithromycinDrug Resistance, BacterialHaemophilusHaemophilus influenzaeHumansMacrolidesQuality of LifeRespiratory SystemAnti-Bacterial AgentsAzithromycinMacrolidesadaptationazithromycinHaemophilus influenzaeHaemophilus parainfluenzaemacrolide resistancepersistence

Identifiers

PMID36475849
PMCPMC9927455
OpenAlexW4310943475

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.